TCRT
TCRT
NASDAQ · Biotechnology

Alaunos Therapeutics Inc

$2.52
+0.00 (+0.00%)
As of May 16, 2:33 AM ET ·
Financial Highlights (FY 2026)
Revenue
6.2K
Net Income
-5,149,004
Gross Margin
Profit Margin
-83,520.0%
Rev Growth
-88.0%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 33.9% 33.9%
Operating Margin -84,500.0% -76,050.1% -6.9% -6.6%
Profit Margin -83,520.0% -79,344.0% -6.2% -6.5%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 6.2K 52.2K 1.35M 1.27M
Gross Profit 457.7K 431.9K
Operating Income -5,277,870 -39,716,413 -93,195 -83,844
Net Income -5,149,004 -38,746,685 -84,207 -82,182
Gross Margin 33.9% 33.9%
Operating Margin -84,500.0% -76,050.1% -6.9% -6.6%
Profit Margin -83,520.0% -79,344.0% -6.2% -6.5%
Rev Growth -88.0% -88.0% +20.4% +2.6%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 2.88M 2.33M
Total Equity 1.84M 1.81M
D/E Ratio 1.56 1.28
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -5,140,355 -40,830,579 -111,401 -119,566
Free Cash Flow -113,905 -126,135